85 Medical Shops in Delhi Still Selling Banned Drugs: DCGI
The DCGI said that a surprise raid on medical shops in New Delhi has revealed that more than half of the shops were selling drugs that have been banned in the country.
The DCGI said that a surprise raid on medical shops in New Delhi has revealed that more than half of the shops were selling drugs that have been banned in the country.
‘In an interim relief for pharmaceutical companies, the Delhi High Court has stayed the ban on 355 drugs till March 28.’
Tweet it Now
This move has offered a breathing relief for drugs manufactured by major pharmaceutical companies like Pfizer’s Corex cough syrup, Glaxo’s Piriton expectorant, P&G’s Vicks Action 500 extra, Reckitt’s D’Cold, Piramal’s Saridon, Glenmark’s Ascoril and Alex cough syrups, Abbott’s Phensedyl cough syrup and Alembic’s Glycodin cough syrup.In their pleas, the companies have stated that the ban on drugs under the Drugs and Cosmetics Act and Rules was issued without giving any show-cause notification or granting them a hearing. Therefore, the court has decided to hear their pleas on March 28.
Source-Medindia
Indian Government Bans Six Drugs Over Safety Issues
Based on the recommendations of the Expert Committee constituted by DTAB, the Central Government has banned the use of six drugs with immediate effect, over safety issues.
Based on the recommendations of the Expert Committee constituted by DTAB, the Central Government has banned the use of six drugs with immediate effect, over safety issues.
Pharmaceutical Company Pfizer Stops Selling Corex in India
The government of India vide notification dated March 10, 2016, has prohibited the manufacture for sale and distribution of cough syrup Corex with immediate effect.
The government of India vide notification dated March 10, 2016, has prohibited the manufacture for sale and distribution of cough syrup Corex with immediate effect.
GlaxoSmithKline Stops Sale of Crocin Cold & Flu Drug
On march 12, the Indian government issued a notification banning the sale of 350 fixed dose combination drugs (FDC’s).
On march 12, the Indian government issued a notification banning the sale of 350 fixed dose combination drugs (FDC’s).
